Spots Global Cancer Trial Database for A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
Official Title: An Open-Label, Randomized, Multicenter Phase III Trial of Dasatinib (SPRYCEL®) vs. Standard Dose Imatinib (400 mg) in the Treatment of Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia
Study ID: NCT00481247
Conditions
Study Description
Brief Summary: The purpose of this clinical research study is to compare the confirmed complete cytogenetic response of dasatinib with that of imatinib within 12 months after randomization in patients with newly diagnosed chronic-phase Philadelphia positive chronic myeloid leukemia. The safety of this treatment will also be studied.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Molecular Md, Portland, Oregon, United States
Local Institution, Capital Federal, Buenos Aires, Argentina
Local Institution, Capital Federal, Buenos Aires, Argentina
Local Institution, Buenos Aires, , Argentina
Local Institution, Waratah, New South Wales, Australia
Local Institution, Brisbane, Queensland, Australia
Local Institution, Greenslopes, Queensland, Australia
Local Institution, Perth, Western Australia, Australia
Local Institution, Innsbruck, , Austria
Local Institution, Wien, , Austria
Local Institution, Brugge, , Belgium
Local Institution, Bruxelles, , Belgium
Local Institution, Curitiba, Parana, Brazil
Local Institution, Campinas, Sao Paulo, Brazil
Local Institution, Jau, Sao Paulo, Brazil
Local Institution, Rio De Janeiro, , Brazil
Local Institution, Sao Paulo, , Brazil
Local Institution, Sao Paulo, , Brazil
Local Institution, Santiago, Metropolitana, Chile
Local Institution, Beijing, Beijing, China
Local Institution, Fuzhou, Fujian, China
Local Institution, Shanghai, Shanghai, China
Local Institution, Tianjin, Tianjin, China
Local Institution, Colombia, Bogota, Colombia
Local Institution, Bogota, , Colombia
Local Institution, Brno, , Czech Republic
Local Institution, Hradec Kralove, , Czech Republic
Local Institution, Olomouc, , Czech Republic
Local Institution, Prague 2, , Czech Republic
Local Institution, Aarhus, , Denmark
Local Institution, Nantes, Cedex 1, France
Local Institution, Brest Cedex 02, , France
Local Institution, Lille Cedex, , France
Local Institution, Limoges, , France
Local Institution, Montpellier Cedex, , France
Local Institution, Paris Cedex 10, , France
Local Institution, Paris, , France
Local Institution, Pierre Benite Cedex, , France
Local Institution, Poitiers Cedex, , France
Local Institution, Rennes, , France
Local Institution, Strasbourg Cedex, , France
Local Institution, Toulouse Cedex 09, , France
Local Institution, Vandoeuvre Les Nancy, , France
Local Institution, Berlin, , Germany
Local Institution, Rostock, , Germany
Local Institution, Tuebingen, , Germany
Local Institution, Ulm, , Germany
Local Institution, Thessaloniki, , Greece
Local Institution, Budapest, , Hungary
Local Institution, Debrecen, , Hungary
Local Institution, Vellore, Tamilnadu, India
Local Institution, Ahmedabad, , India
Local Institution, Cochin, , India
Local Institution, Mumbai, , India
Local Institution, Mumbai, , India
Local Institution, Mumbai, , India
Local Institution, Trivandrum, , India
Local Institution, Bologna, , Italy
Local Institution, Catania, , Italy
Local Institution, Monza (mb), , Italy
Local Institution, Orbassano (to), , Italy
Local Institution, Pavia, , Italy
Local Institution, Roma, , Italy
Local Institution, Roma, , Italy
Local Institution, Nagoya, Aichi, Japan
Local Institution, Kamogawa-shi, Chiba, Japan
Local Institution, Fukuoka-shi, Fukuoka, Japan
Local Institution, Morioka-shi, Iwate, Japan
Local Institution, Kagoshima-shi, Kagoshima, Japan
Local Institution, Yokohama, Kanagawa, Japan
Local Institution, Kyoto-shi, Kyoto, Japan
Local Institution, Sendai, Miyagi, Japan
Local Institution, Okayama-shi, Okayama, Japan
Local Institution, Osaka-shi, Osaka, Japan
Local Institution, Bunkyo-ku, Tokyo, Japan
Local Institution, Shinagawa-ku, Tokyo, Japan
Local Institution, Seoul, , Korea, Republic of
Local Institution, Seoul, , Korea, Republic of
Local Institution, Mexico D.f., Distrito Federal, Mexico
Local Institution, Mexico, D. F., Distrito Federal, Mexico
Local Institution, Mexico, Distrito Federal, Mexico
Local Institution, Monterrey, Nuevo Leon, Mexico
Local Institution, Culiacan, Sinaloa, Mexico
Local Institution, Groningen, , Netherlands
Local Institution, Nijmegen, , Netherlands
Local Institution, Arequipa, , Peru
Local Institution, Lima, , Peru
Local Institution, Lima, , Peru
Local Institution, Chorzow, , Poland
Local Institution, Krakow, , Poland
Local Institution, Lodz, , Poland
Local Institution, Poznan, , Poland
Local Institution, Warsaw, , Poland
Local Institution, Moscow, , Russian Federation
Local Institution, Rostov-on-don, , Russian Federation
Local Institution, St.petersburg, , Russian Federation
Local Institution, Singapore, , Singapore
Local Institution, A Coruna, , Spain
Local Institution, Barcelona, , Spain
Local Institution, Barcelona, , Spain
Local Institution, Barcelona, , Spain
Local Institution, Madrid, , Spain
Local Institution, Madrid, , Spain
Local Institution, Malaga, , Spain
Local Institution, Oviedo, , Spain
Local Institution, Salamanca, , Spain
Local Institution, Valencia, , Spain
Local Institution, Ankara, , Turkey
Local Institution, Kayseri, , Turkey
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
